Zobrazeno 1 - 10 of 72 pro vyhledávání: '"Paltuev Rm"'
1
Akademický článek
Tailoring neoadjuvant systemic therapy in breast cancer: "The advent of a personalized approach"-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendations.
Autor: Elghazaly H; Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Azim HA; Department of Clinical Oncology, Kasr Alainy School of Medicine, Cairo University, Giza, Egypt., Rugo HS; Department of Medicine, University of California San Francisco Comprehensive Cancer Center, San Francisco, California, USA., Cameron D; Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh and National Health Service Lothian, Edinburgh, UK., Swain SM; Georgetown Lombardi Comprehensive Cancer Center, MedStar Health, Washington, District of Columbia, USA., Curigliano G; Department of Oncology and Hemato-Oncology, European Institute of Oncology, IRCCS, University of Milano, Milan, Italy., Harbeck N; Department of Obstetrics and Gynecology and Comprehensive Cancer Center Munich, Breast Center, Ludwig Maximilian University Hospital, Munich, Germany., Tripathy D; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Arun B; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Aapro M; Breast Center, Clinique de Genolier, Genolier, Switzerland., Piccart M; Institut Jules Bordet and L'Université Libre de Bruxelles, Brussels, Belgium., Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal., Gligorov J; Medical Oncology Department, L'Assistance Publique-Hôpitaux de Paris, Institute Universitaire de Cancérologie, Sorbonne Université, Paris, France., Elghazawy H; Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt., El Saghir NS; Division of Hematology Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon., Penault-Llorca F; National Institute of Health and Medical Research Unit 1240 'Molecular Imaging and Theranostic Strategies', Department of Pathology, Clermont Auvergne University, Center Jean Perrin, Clermont-Ferrand, France., Perez EA; Department of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida, USA., Poortmans P; Iridium Network and Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk-Antwerp, Belgium., Abdelaziz H; Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt., El-Zawahry HM; Department of Clinical Oncology, Kasr Alainy School of Medicine, Cairo University, Giza, Egypt., Kassem L; Department of Clinical Oncology, Kasr Alainy School of Medicine, Cairo University, Giza, Egypt., Sabry M; Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Viale G; European Institute of Oncology, IRCCS, Milan, Italy., Al-Sukhun S; Al Hyatt Oncology Practice, Amman, Jordan., Gado N; Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Leung JWT; Department of Breast Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ezz Elarab L; Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Cardoso MJ; Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Faculdade de Medicina, Lisbon, Portugal., Abdel Karim K; Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Foheidi M; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Adult Medical Oncology, Princess Noorah Oncology Center, King Abdulaziz Medical City, Ministry of National Guard Health Affairs-Western Region, Jeddah, Saudi Arabia., Elmaadawy MM; Diagnostic Radiology Department, Mansoura University, Mansoura, Egypt., Conte P; Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy.; Division of Oncology, Istituto Oncologico Veneto-IRCCS, Padova, Italy., Selim ASM; Diagnostic and Interventional Radiology Department, Cairo University, Giza, Egypt., Kandil A; Department of Clinical Oncology, Alexandria School of Medicine, Alexandria, Egypt., Kamal RM; Diagnostic and Interventional Radiology Department, Cairo University, Giza, Egypt., Paltuev RM; Department of Breast Tumours of Federal State Budgetary Institution 'Petrov Research Institute of Oncology', Russian Association of Oncological Mammology, St Petersburg, Russia., Guarneri V; Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy.; Division of Oncology, Istituto Oncologico Veneto-IRCCS, Padova, Italy., Abulkhair O; Medical Oncology Department, Oncology Services, Alhabib Hospital, Riyad, Saudi Arabia., Zakaria O; Department of Surgery, Cairo University, Cairo, Egypt., Golshan M; Department of Surgery, Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut, USA., Orecchia R; Scientific Directorate, IRCCS European Institute of Oncology, University of Milan, Milan, Italy., ElMahdy M; Department of Pathology, Ain Shams University, Cairo, Egypt., Abdel-Aziz AM; Department of Pathology, Faculty of Medicine, Cairo University, Giza, Egypt., Eldin NB; Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Publikováno v: Cancer [Cancer] 2024 Oct 01; Vol. 130 (19), pp. 3251-3271. Date of Electronic Publication: 2024 Jul 10.
Zobrazit plný text záznamu
2
EXPERIENCE OF SENTINEL LYMPH NODE BIOPSY AFTER NEOADJUVANT CHEMOTHERAPY
Autor: Petr Krivorotko, Trufanova Es, A.S. Artemyeva, Tengiz Tabagua, Sergey Kanaev, Victor G. Ivanov, Aleksandr Komyakhov, S. Nonikov, L. Gigolaeva, Paltuev Rm, V F Semiglazov, Aleksandr Bessonov, K. Zernov, Elena Zhiltsova, A. Emelyanov, G.A. Dashyan, Vladimir Semiglazov, Ivanova Oa, Pavel Krzhivitskiy, Bus'ko Ea, Antonina Chernaya, Kirill Nikolaev
Publikováno v: Problems in oncology. 66:370-375
Objective: to evaluate the diagnostic accuracy of sentinel lymph node biopsy after neoadjuvant chemotherapy. Materials and methods: the study included 264 patients with early (operable) and locally advanced breast cancer (cT1N1-3, cT2N0-3, cT3N0-3, c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7a8aefffbad67432cdc4fb940c10b89b
https://doi.org/10.37469/0507-3758-2020-66-4-370-375
Zobrazit plný text záznamu
3
Correlation of the value of sonoelastography strain ratio with the degree of pathological regression in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy
Autor: Anna Petrova, V F Semiglazov, Aleksandr Komyakhov, T Yu Semiglazova, Andrey Mishchenko, Paltuev Rm, Bus'ko Ea, P. Krivorotko, Vladislav Semiglazov
Publikováno v: Opuholi Ženskoj Reproduktivnoj Sistemy, Vol 12, Iss 4, Pp 25-31 (2017)
The article presents the data on capability of sonoelastography for the evaluation of neoadjuvant chemotherapy effectiveness in breast cancer. Qualitative and quantitative changes of the strain ratio correlate with the degree of pathological regressi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15455c7165157cb55a9a9d140b1c2af5
https://ojrs.abvpress.ru/ojrs/article/view/521
Zobrazit plný text záznamu
4
New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer
Autor: V F Semiglazov, P. Krivorotko, Gulfiya Midhatovna Teletaeva, Paltuev Rm, R V Donskikh, Tkachenko Ev, V. A. Klyuge, T Yu Semiglazova, G.A. Dashyan, Vladislav Semiglazov
Publikováno v: Современная онкология, Vol 18, Iss 2, Pp 27-33 (2016)
Since 1990-s the efficiency of treatment of patients with metastatic/advanced breast cancer (MBC) was started to evaluate not only by overall survival but also by quality of life which is characterized by physical, social, mental and emotional condit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ed0f15608368d0042a5612767e31f07
https://modernonco.orscience.ru/1815-1434/article/viewFile/27066/pdf
Zobrazit plný text záznamu
6
Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer.
Autor: Elghazaly H; Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt., Rugo HS; Department of Medicine, University of California San Francisco Comprehensive Cancer Center, San Francisco, CA 94158, USA., Azim HA; Clinical Oncology Department, Kasr Alainy School of Medicine, Cairo University, Giza 12613, Egypt., Swain SM; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, MedStar Health, Washington, DC 20007, USA., Arun B; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Aapro M; Breast Center, Clinique de Genolier, 1272 Genolier, Switzerland., Perez EA; Department of Hematology & Oncology, Mayo Clinic, Jacksonville, FL 32224, USA., Anderson BO; Breast Health Global Initiative, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA 98195, USA., Penault-Llorca F; Department of Pathology, Clermont Auvergne University, INSERM U1240 'Molecular Imaging and Theranostic Strategies', Center Jean Perrin, Montalembert, 63000 Clermont-Ferrand, France., Conte P; Department of Surgery, Oncology and Gastroenterology, University of Padova, Istituto Oncologico Veneto IOV IRCCS, 35128 Padova, Italy., El Saghir NS; Department of Internal Medicine, Division of Hematology Oncology, American University of Beirut Medical Center, Beirut 1107 2020, Lebanon., Yip CH; Subang Jaya Medical Centre, Kuala Lumpur 47500, Malaysia., Ghosn M; Hematology and Oncology Department, Saint Joseph University, Beirut 1104 2020, Lebanon., Poortmans P; Iridium Kankernetwerk and Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Wilrijk-Antwerp, Belgium., Shehata MA; Clinical oncology Department, Menoufia University, Shebin Elkom 51132, Egypt., Giuliano AE; Department of Surgery, Surgical Oncology Division, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Leung JWT; Department of Breast Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova, Istituto Oncologico Veneto IOV IRCCS, 35128 Padova, Italy., Gligorov J; Institut Universitaire de Cancérologie AP-HP. Sorbonne Université, INSERM U938, 75013 Paris, France., Gulluoglu BM; Breast & Endocrine Surgery Unit, Marmara University School of Medicine, University Hospital, Istanbul 34722, Turkey., Abdel Aziz H; Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt., Frolova M; Federal State Budgetary Institution 'NN Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, 127994 Moscow, Russia., Sabry M; Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt., Balch CM; Surgical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Orecchia R; Scientific Directorate, IRCCS European Institute of Oncology (IEO), and University of Milan, 20122 Milan, Italy., El-Zawahry HM; Clinical Oncology Department, Kasr Alainy School of Medicine, Cairo University, Giza 12613, Egypt., Al-Sukhun S; Al Hyatt Oncology Practice, Amman 11183, Jordan., Abdel Karim K; Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt., Kandil A; Department of Clinical Oncology, Alexandria School of Medicine, Alexandria 21131, Egypt., Paltuev RM; Russian Association of Oncological Mammology, Department of Breast Tumours of Federal State Budgetary Institution 'Petrov Research Institute of Oncology', 197758 Saint Petersburg, Russia., Foheidi M; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Adult Medical Oncology, Princess Noorah Oncology Center, King Abdulaziz Medical City, Ministry of National Guard Health Affairs-Western Region, Jeddah 22384, Saudi Arabia., El-Shinawi M; Department of General Surgery, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt.; Vice President of Galala University, Galala University, Suez 435611, Egypt., ElMahdy M; Department of Pathology, Ain shams University, Cairo 11566, Egypt., Abulkhair O; Oncology Department, Alfaisal university, Alhabib Hospital, Riyad 11533, Saudi Arabia., Yang W; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China., Aref AT; The School of Public Health, University of Adelaide, Adelaide 5005, Australia., Bakkach J; Biomedical Genomics & Oncogenetics Research Laboratory, Faculty of Sciences and Techniques of Tangier, Abdel Malek Essaadi University, Tangier 90000, Morocco., Bahie Eldin N; Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt., Elghazawy H; Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt.
Publikováno v: Cancers [Cancers (Basel)] 2021 May 08; Vol. 13 (9). Date of Electronic Publication: 2021 May 08.
Zobrazit plný text záznamu
8
Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer
Autor: Bozhok Aa, G.A. Dashyan, Vadim G. Ivanov, Alexander Kletzel, E.K. Ziltsova, Vladimir Semiglazov, Olga A. Melnikova, Vladislav Semiglazov, L. M. Berstein, Paltuev Rm
Publikováno v: Cancer. 110:244-254
BACKGROUND. Few studies have compared primary neoadjuvant endocrine therapy with neoadjuvant chemotherapy in breast cancer patients. The need for preoperative chemotherapy with doxorubicin or taxanes may be reduced in postmenopausal patients with est
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fb52c6ccf741e9726746737e3faa973
https://doi.org/10.1002/cncr.22789
Zobrazit plný text záznamu
9
Akademický článek
Cytotoxic and cytostatic activity of five new imidazotetrazine derivatives on breast cancer cell cultures MDAMB231, BT474, and MCF-7.
Autor: Al-Humairi, Ahmed Hamid1,2 ahmed.h.mneahil@gmail.com, Sitnikova, Svetlana E.1 sesitnikova@volgmed.ru, Novochadov, Valery V.3 novochadov.valeriy@volsu.ru
Publikováno v: Research Results in Pharmacology. 2024, Vol. 10 Issue 3, p33-42. 10p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje